We further used a label-free quantitative proteomic profiling to identify the role of PPL at the hepatic tissue proteomic level to explore the key protein and molecular mechanisms underlying PPL protection against NAFLD. The gene discussed is PPL; the disease is metabolic dysfunction-associated steatotic liver disease.